Abstract:In SH-SY5Y human neuroblastoma cells, insulin-like growth factor (IGF)-l mediates membrane ruffling and growth cone extension. We have previously shown that IGF-l activates the tyrosine phosphorylation of focal adhesion kinase (FAK) and extracellular signal-regulated protein kinase (ERK) 2. In the current study, we examined which signaling pathway underlies IGF-I-mediated FAK phosphorylation and cytoskeletal changes and determined if an intact cytoskeleton was required for IGF-I signaling. Treatment of SH-SY5Y cells with cytochalasin D disrupted the actin cytoskeleton and prevented any morphological changes induced by IGF-I. Inhibitors of phosphatidylinositol 3-kinase (P1 3-K) blocked IGF-l-mediated changes in the actin cytoskeleton as measured by membrane ruffling. In contrast, P098059, a selective inhibitor of ERK kinase, had no effect on IGF-l-induced membrane ruffling. In parallel with effects on the actin cytoskeleton, cytochalasin D and P1 3-K inhibitors blocked IGF-l-induced FAK tyrosine phosphorylation, whereas PD98059 had no effect. It is interesting that cytochalasin D did not block IGF-l-induced ERK2 tyrosine phosphorylation. Therefore, it is likely that FAK and ERK2 tyrosine phosphorylations are regulated by separate pathways during IGF-l signaling. Our study suggests that integrity as well as dynamic motility of the actin cytoskeleton mediated by P1 3-K is required for IGF-I-induced FAK tyrosirle phosphorylation, but not for ERK2 activation. Key Words: Insulin-like growth factor 1-Actin cytoskeleton-Focal adhesion kinase-Extracellular signal-regulated protein kinase-Phosphatidylinositol 3-kinase. J. Neurochem. 71, 1333Neurochem. 71, -1336Neurochem. 71, (1998.Insulin-like growth factor (IGF)-I is a polypeptide that plays an essential role in embryonic and early postnatal development (Zackenfels et al., 1995). In the nervous system, IGF-I is important for cytoskeletal organization and extension of growth cones. These changes in neuronal architecture require IGF-I-mediated redistribution of the actin cytoskeleton (Kadowaki et al., 1986;.We are interested in the downstream signaling pathways activated by IGF-I during nervous system growth. We have reported that IGF-I binds to the type I IGF receptor and activates the mitogen-activated protein (MAP) kinase and phosphatidylinositol 3-kinase (P1 3-K) pathways Leventhal and Feldman, 1997;Leventhal et al., 1997;Cheng and Feldman, 1998). Our work suggests that the physiological effects of each pathway are separable. For example, IGF-I activation of extracellular signal-regulated protein kinase (ERK) 2, the most studied member of the MAP kinase family, results in neuronal differentiation , whereas IGF-I blocks neuronal apoptosis via P1 3-K signaling (Singleton et al., 1996). We do not know the relationship between these two pathways and the ability of IGF-I to reorganize the actin cytoskeleton. Furthermore, it is not known if cytoskeletal organization is a prerequisite for one or more aspects of IGF-I-mediated signaling.To answer these questions, w...